Please assess the completion status of the following clinical trial:

Trial Title: A Study Of PF-06664178 In Patients With Advanced Solid Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of solid tumor that is advanced/metastatic and resistant to standard therapy or for whom no standard therapy is available~* Performance Status of 0 or 1~* Adequate bone marrow, kidney and liver function~* Part 2 includes target expressing NSCLC, ovarian or breast cancer patients~Exclusion Criteria:~* Brain metastases requiring steroids~* Major surgery, radiation therapy, or systemic anti-cancer therapy within 4 weeks of study treatment start (6 weeks for mitomycin C or nitrosoureas)~* Active and clinically significant bacterial, fungal, or viral infection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PF-06664178 (Type: EXPERIMENTAL): Experimental

Based on this trial design, predict the completion outcome and termination type (if applicable).